What is Capricor Therapeutics's net change in cash?

Capricor Therapeutics (CAPR) reported net change in cash of -$182.43M in Q1 2026.

How has Capricor Therapeutics's net change in cash changed year-over-year?

Capricor Therapeutics's net change in cash decreased by 1142.0% year-over-year, from $17.51M to -$182.43M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Capricor Therapeutics CAPR Net Change in Cash

Net Change in Cash at other companies

PfizerPFE

$563M+50.1%

Sarepta Therapeutics, Inc.SRPT

-$336.83M+60.9%

PTC TherapeuticsPTCT

-$147.9M-121%

Celldex TherapeuticsCLDX

$6.86M+161%

VericelVCEL

$9.2M+272%

Dyne Therapeutics, Inc.DYN

-$140.25M-481%

Other financials

Income statement

See full

Revenue--100%

Operating income-$36.8M-47.2%

Net income-$33.9M-39.2%

EPS (diluted)-$0.59-11.3%

Balance sheet

See full

Cash & equivalents$105.4M+266%

Total debt$14.8M+1,083%

Total equity$278.7M+118%

Total assets$326.3M+112%

Cash flow

See full

Operating cash flow-$29.3M-355%

CapEx$5.1M+472%

Free cash flow-$34.4M-369%

Valuation

See full

Market cap$1.71B+303%

Profitability

See full

Operating margin-778.8%-1,038pp

Net margin-736.6%-981pp

FCF margin-563.9%-954pp

Returns & leverage

See full

Return on equity-56.4%-11.3pp

Debt / equity0.1×0.0×

Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Capricor Therapeutics's net change in cash?: Capricor Therapeutics (CAPR) reported net change in cash of -$182.43M in Q1 2026.
How has Capricor Therapeutics's net change in cash changed year-over-year?: Capricor Therapeutics's net change in cash decreased by 1142.0% year-over-year, from $17.51M to -$182.43M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.